Value-Based Care

An expanded partnership between GENESIS Pharma and Alnylam is set to bring revolutionary RNAi therapies to the Nordics. But can it navigate the region's tough economic hurdles?

With its pivotal Phase 3 trial complete, Rafael Holdings is on a path to redefine treatment for NPC and transform itself into a commercial-stage biotech.

Asante and WesternU launch a strategic partnership to embed medical students in the Rogue Valley, tackling physician shortages with a 'grow your own' model.

Facing a complex and costly senior care market, two disabled veterans launch Trua of Greater Boston, a free service aimed at providing compassionate guidance.

New long-term data for masitinib shows a near doubling of 5-year survival for ALS patients, with many maintaining quality of life. Is this the turning point?

A strategic leadership shift at BoldAge PACE signals a major push to expand its home-based senior care model, aiming to transform how America ages.

Arlow's new platform moves beyond reactive crisis management, using a hybrid AI and human-led system to proactively manage the entire aging journey.

Dana-Farber's historic $50M Yawkey grant funds more than a building; it fuels a new era of integrated research and patient-centric cancer treatment.

A new survey reveals a massive consumer shift from processed proteins to whole foods, challenging the food-tech narrative and forcing a re-evaluation of innovation.

As staffing crises cripple New England hospitals, York Hospital's partnership with ShiftMed offers a tech-driven fix. But is the gig model the ultimate cure?

Phase 2a data shows a new drug not only stops bone-destroying cancer but heals the damage, with no adverse events. This is a strategic game-changer.

A $20M round for CELYSTRA Pharma isn't just a launch; it's a strategic maneuver to solve Canada's rare disease gap and redefine Québec's role in the market.

As corporate giants swallow local clinics, one alliance offers a lifeline. Here’s how AllyGPO and BioCareSD use AI and service to help doctors stay independent.

EVERSANA poaches Takeda's Jen Norton to lead a new tech-first unit, signaling a high-stakes bid to dominate the complex life sciences access market.

Essence Healthcare and ŌURA's new partnership uses sleep data to screen for sleep apnea, marking a major shift from wellness perks to proactive clinical care.

Priority Health partners with Color Health, leveraging an ASCO-certified virtual clinic to tackle soaring cancer costs and redefine access for employers.

Blue Cross MA's new partnership with Thyme Care moves beyond paying for procedures, betting on a value-based model to guide patients and curb spiraling costs.

Charta Health's new athenahealth partnership promises an 11% revenue lift by auditing every bill. We analyze if AI is the long-awaited cure for revenue leakage.

A new clinical trial for a sacroiliac joint device isn't just about technology; it's about a company's bet that rigorous evidence is the best medicine for patients and the healthcare system.

A new Philips report quantifies AI's benefits in healthcare, from saving time to catching errors. But the path to adoption is fraught with challenges.